Stock Screener App

Frei -

Installieren

4.37

1.35% -0.09

Taysha Gene Therapies Inc (TSHA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Taysha Gene Therapies Inc-Aktie (TSHA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.73% 1.986	2.302	2.022	1.788	1.112
Operating Expenses	21.14% 28.74	23.72	21.95	27.69	22.41
Benefits Costs and Expenses	21.14% 28.87	23.83	20.81	-	-
Costs And Expenses	21.14% 28.87	23.83	20.81	27.69	22.41
Operating Income/Loss	24.89% -26.75	-21.42	-19.93	-25.90	-21.30
Nonoperating Income/Loss	19.44% -0.129	-0.108	1.147	0.374	0.371
Income/Loss From Continuing Operations Before Tax	24.86% -26.88	-21.53	-18.79	1.788	1.112
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	24.86% -26.88	-21.53	-18.79	-25.52	-20.93
Net Income/Loss	24.86% -26.88	-21.53	-18.79	-25.52	-20.93
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	10.65% 297.99	269.31	6.0824	267.82	232.82
Diluted Average Shares	10.65% 297.99	269.31	6.0824	267.82	232.82
Basic Earnings Per Share	12.50% -0.09	-0.08	-0.07	-0.10	-0.09
Diluted Earnings Per Share	12.50% -0.09	-0.08	-0.07	-0.10	-0.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.82

1.53%

GMAB

$29.27

2.02%

INCY

$103.10

1.51%

BNTX

$104.49

0.38%

ONC

$315.46

0.94%

INSM

$185.68

0.27%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters